{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:35:03Z","timestamp":1786980903312,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T00:00:00Z","timestamp":1479254400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10620-016-4374-0","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T02:57:31Z","timestamp":1479351451000},"page":"473-480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8749-651X","authenticated-orcid":false,"given":"Caroline","family":"Prieux-Klotz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Nahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelien","family":"Amiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Sinayoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Gal\u00e9ano-Cassaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Chaussade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Coriat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Lahmek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vered","family":"Abitbol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,16]]},"reference":[{"key":"4374_CR1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.lpm.2014.06.025","volume":"44","author":"C Klotz","year":"2015","unstructured":"Klotz C, Barret M, Dhooge M, et al. Management of diagnosis and treatment in ulcerative colitis. Presse M\u00e9d. 2015;44:144\u2013149.","journal-title":"Presse M\u00e9d"},{"key":"4374_CR2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.crohns.2012.09.002","volume":"6","author":"A Dignass","year":"2012","unstructured":"Dignass A, Lindsay JO, Sturm A, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis. 2012;6:991\u20131030.","journal-title":"J Crohns Colitis"},{"key":"4374_CR3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ejim.2011.06.017","volume":"22","author":"N L\u00f3pez-Palacios","year":"2011","unstructured":"L\u00f3pez-Palacios N, Mendoza JL, Taxonera C, et al. Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy. Eur J Intern Med. 2011;22:621\u2013625.","journal-title":"Eur J Intern Med"},{"key":"4374_CR4","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/j.gastro.2011.06.054","volume":"141","author":"JF Colombel","year":"2011","unstructured":"Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011;141:1194\u20131201.","journal-title":"Gastroenterology"},{"key":"4374_CR5","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/apt.12289","volume":"37","author":"D Laharie","year":"2013","unstructured":"Laharie D, Filippi J, Roblin X, et al. Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience. Aliment Pharmacol Ther. 2013;37:998\u20131004.","journal-title":"Aliment Pharmacol Ther"},{"key":"4374_CR6","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1053\/j.gastro.2007.08.001","volume":"133","author":"RB Gupta","year":"2007","unstructured":"Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099\u20131105.","journal-title":"Gastroenterology"},{"key":"4374_CR7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","volume":"126","author":"M Rutter","year":"2004","unstructured":"Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451\u2013459.","journal-title":"Gastroenterology"},{"key":"4374_CR8","first-page":"929","volume":"12","author":"L Peyrin-Biroulet","year":"2014","unstructured":"Peyrin-Biroulet L, Bressenot A, Kampman W. Histologic remission: the ultimate therapeutic goal in ulcerative colitis? Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2014;12:929\u2013934.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"4374_CR9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/gut.2008.154302","volume":"58","author":"W Kruis","year":"2009","unstructured":"Kruis W, Kiudelis G, R\u00e1cz I, et al. Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial. Gut. 2009;58:233\u2013240.","journal-title":"Gut"},{"key":"4374_CR10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.crohns.2011.10.006","volume":"6","author":"B Bokemeyer","year":"2012","unstructured":"Bokemeyer B, Hommes D, Gill I, et al. Mesalazine in left-sided ulcerative colitis: efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing. J Crohns Colitis. 2012;6:476\u2013482.","journal-title":"J Crohns Colitis"},{"key":"4374_CR11","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","volume":"353","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462\u20132476.","journal-title":"N Engl J Med"},{"key":"4374_CR12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2011.10.032","volume":"142","author":"WJ Sandborn","year":"2012","unstructured":"Sandborn WJ, van Assche G, Reinisch W, et al. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2012;142:257\u2013265.","journal-title":"Gastroenterology"},{"key":"4374_CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/gut.2005.068809","volume":"55","author":"S Ardizzone","year":"2006","unstructured":"Ardizzone S, Maconi G, Russo A, et al. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut. 2006;55:47\u201353.","journal-title":"Gut"},{"key":"4374_CR14","first-page":"CD000478","volume":"9","author":"A Timmer","year":"2012","unstructured":"Timmer A, McDonald JWD, Tsoulis DJ, et al. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2012;9:CD000478.","journal-title":"Cochrane Database Syst Rev."},{"key":"4374_CR15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5217\/ir.2015.13.3.250","volume":"13","author":"S Yamada","year":"2015","unstructured":"Yamada S, Yoshino T, Matsuura M, et al. Efficacy and safety of long-term thiopurine maintenance treatment in japanese patients with ulcerative colitis. Intest Res. 2015;13:250\u2013258.","journal-title":"Intest Res."},{"key":"4374_CR16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2013.10.052","volume":"146","author":"R Panaccione","year":"2014","unstructured":"Panaccione R, Ghosh S, Middleton S, et al. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. Gastroenterology. 2014;146:392\u2013400.","journal-title":"Gastroenterology"},{"key":"4374_CR17","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A\u201336A.","journal-title":"Can J Gastroenterol."},{"key":"4374_CR18","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ibd.20520","volume":"14","author":"JD Lewis","year":"2008","unstructured":"Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660\u20131666.","journal-title":"Inflamm Bowel Dis"},{"key":"4374_CR19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/gutjnl-2011-300486","volume":"61","author":"SPL Travis","year":"2012","unstructured":"Travis SPL, Schnell D, Krzeski P, et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut. 2012;61:535\u2013542.","journal-title":"Gut"},{"key":"4374_CR20","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1136\/gutjnl-2014-307477","volume":"64","author":"A Bressenot","year":"2015","unstructured":"Bressenot A, Salleron J, Bastien C, et al. Comparing histological activity indexes in UC. Gut. 2015;64:1412\u20131418.","journal-title":"Gut"},{"key":"4374_CR21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","volume":"132","author":"G D\u2019Haens","year":"2007","unstructured":"D\u2019Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007;132:763\u2013786.","journal-title":"Gastroenterology"},{"key":"4374_CR22","doi-asserted-by":"publisher","unstructured":"Sutherland L, Roth D, Beck P, et al. Oral 5-aminosalicylic acid for maintaining remission in ulcerative colitis. Cochrane Database Syst Rev. 2000;CD000544. doi: 10.1002\/14651858.CD000544 .","DOI":"10.1002\/14651858.CD000544"},{"key":"4374_CR23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2013.06.010","volume":"146","author":"WJ Sandborn","year":"2014","unstructured":"Sandborn WJ, Feagan BG, PURSUIT-Maintenance Study Group, et al. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2014;146:96\u2013109.","journal-title":"Gastroenterology"},{"key":"4374_CR24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrgastro.2009.203","volume":"7","author":"G Pineton de Chambrun","year":"2010","unstructured":"Pineton de Chambrun G, Peyrin-Biroulet L, L\u00e9mann M, et al. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol. 2010;7:15\u201329.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4374_CR25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.gastro.2013.07.024","volume":"145","author":"SPL Travis","year":"2013","unstructured":"Travis SPL, Schnell D, Krzeski P, et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013;145:987\u2013995.","journal-title":"Gastroenterology"},{"key":"4374_CR26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ecco-jcc\/jjv077","volume":"9","author":"SPL Travis","year":"2015","unstructured":"Travis SPL, Schnell D, Feagan BG, et al. The impact of clinical information on the assessment of endoscopic activity: characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS]. J Crohns Colitis. 2015;9:607\u2013616.","journal-title":"J Crohns Colitis"},{"key":"4374_CR27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","volume":"369","author":"BG Feagan","year":"2013","unstructured":"Feagan BG, Rutgeerts P, GEMINI 1 Study Group, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013;369:699\u2013710.","journal-title":"N Engl J Med"},{"key":"4374_CR28","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/gut.2010.221127","volume":"60","author":"W Reinisch","year":"2011","unstructured":"Reinisch W, Sandborn WJ, Hommes DW, et al. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. Gut. 2011;60:780\u2013787.","journal-title":"Gut"},{"key":"4374_CR29","first-page":"1181","volume":"64","author":"C Manginot","year":"2014","unstructured":"Manginot C, Baumann C, Peyrin-Biroulet L. An endoscopic Mayo score of 0 is associated with a lower risk of colectomy than a score of 1 in ulcerative colitis. Gut. 2014;64:1181\u20131182.","journal-title":"Gut"},{"key":"4374_CR30","doi-asserted-by":"publisher","first-page":"192794","DOI":"10.1155\/2013\/192794","volume":"2013","author":"K Yokoyama","year":"2013","unstructured":"Yokoyama K, Kobayashi K, Mukae M, et al. Clinical study of the relation between mucosal healing and long-term outcomes in ulcerative colitis. Gastroenterol Res Pract. 2013;2013:192794. doi: 10.1155\/2013\/192794 .","journal-title":"Gastroenterol Res Pract."},{"key":"4374_CR31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/gutjnl-2015-309598","volume":"65","author":"RV Bryant","year":"2015","unstructured":"Bryant RV, Burger DC, Delo J, et al. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6\u2005years of follow-up. Gut. 2015;65:408\u2013414.","journal-title":"Gut"},{"key":"4374_CR32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/apt.13017","volume":"41","author":"V Chhaya","year":"2015","unstructured":"Chhaya V, Saxena S, Cecil E, et al. The impact of timing and duration of thiopurine treatment on colectomy in ulcerative colitis: a national population-based study of incident cases between 1989\u20132009. Aliment Pharmacol Ther. 2015;41:87\u201398.","journal-title":"Aliment Pharmacol Ther"},{"key":"4374_CR33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ecco-jcc\/jju010","volume":"9","author":"R Sood","year":"2015","unstructured":"Sood R, Ansari S, Clark T, et al. Long-term efficacy and safety of azathioprine in ulcerative colitis. J Crohns Colitis. 2015;9:191\u2013197.","journal-title":"J Crohns Colitis."},{"key":"4374_CR34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/00365520802600961","volume":"44","author":"IC Solberg","year":"2009","unstructured":"Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10\u00a0years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431\u2013440.","journal-title":"Scand J Gastroenterol"},{"key":"4374_CR35","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1097\/MIB.0000000000000447","volume":"21","author":"H-S Lee","year":"2015","unstructured":"Lee H-S, Yang S-K, Soh JS, et al. Short- and long-term outcomes of acute severe ulcerative colitis in Korea: the 1999\u20132005 Cohort. Inflamm Bowel Dis. 2015;21:1825\u20131831.","journal-title":"Inflamm Bowel Dis"},{"key":"4374_CR36","doi-asserted-by":"crossref","unstructured":"O\u2019Byrne S, Keir ME, Cabanski CR et al. Rectal bleeding accurately reflects level of mucosal inflammation in patients with ulcerative colitis. Gastroenterology. 2015; 4:Su 1220.","DOI":"10.1016\/S0016-5085(15)31491-8"},{"key":"4374_CR37","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/MIB.0000000000000302","volume":"21","author":"G Bouguen","year":"2015","unstructured":"Bouguen G, Sninsky C, Tang KL, et al. Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC. Inflamm Bowel Dis. 2015;21:606\u2013614.","journal-title":"Inflamm Bowel Dis"},{"key":"4374_CR38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10620-015-3864-9","volume":"61","author":"SD Thapa","year":"2016","unstructured":"Thapa SD, Hadid H, Usman M, et al. Predictors of thiopurine treatment failure in biologic-na\u00efve ulcerative colitis patients. Dig Dis Sci. 2016;61:230\u2013237.","journal-title":"Dig Dis Sci"},{"key":"4374_CR39","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00228-008-0478-6","volume":"64","author":"S Sahasranaman","year":"2008","unstructured":"Sahasranaman S, Howard D, Roy S. Clinical pharmacology and pharmacogenetics of thiopurines. Eur J Clin Pharmacol. 2008;64:753\u2013767.","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4374-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-016-4374-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4374-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T19:08:19Z","timestamp":1657739299000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-016-4374-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,16]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["4374"],"URL":"https:\/\/doi.org\/10.1007\/s10620-016-4374-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,16]]}}}